Health Care & Life Sciences » Pharmaceuticals | Corium International Inc.

Corium International Inc. | Ownership

Companies that own Corium International Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Perceptive Advisors LLC
6,357,133
17.54%
0
1.41%
06/30/2018
Broadfin Capital LLC
3,597,057
9.92%
477,412
4.83%
06/30/2018
AWM Investment Co., Inc.
2,293,343
6.33%
25,000
3.44%
06/30/2018
BlackRock Fund Advisors
2,083,681
5.75%
289,509
0%
06/30/2018
Franklin Advisers, Inc.
2,028,929
5.6%
385
0.01%
06/30/2018
RTW Investments LP
1,923,217
5.31%
12,695
1.08%
06/30/2018
Ridgeback Capital Management LP
1,565,934
4.32%
1,565,934
21%
03/15/2018
The Vanguard Group, Inc.
1,403,480
3.87%
233,940
0%
06/30/2018
Tamarack Advisers LP
1,364,279
3.76%
259,279
3.92%
06/30/2018
Opaleye Management, Inc.
800,000
2.21%
-265,000
1.97%
06/30/2018

About Corium International

View Profile
Address
235 Constitution Drive
Menlo Park California 94025
United States
Employees -
Website http://www.coriumgroup.com
Updated 09/14/2018
Corium International, Inc. is a commercial stage biopharmaceutical company, which develops, manufactures and commercializes pharmaceutical products. The company development platforms enable transdermal delivery of large molecules or biologics, including vaccines, peptides and proteins, as well as small molecules that are otherwise difficult to deliver in a transdermal dosage form. The firm offers its products under the brands Corplex and MicroCor.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.